Latest News about Gene Therapy
Recent news which mentions Gene Therapy
Join CRB for a Biomanufacturing Manufacturing Solutions Webinar
December 09, 2020
Tickers
CRB
OutcomeRx, a unit of CareMetx, announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies
November 19, 2020
Tickers
AP
From Send2Press Newswire
Facing Pandemics and Emerging Threats, ATMP Industry Arrives at Intersection of Obstacle and Opportunity
October 28, 2020
Tickers
CRB
From Benzinga
CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines
September 30, 2020
Tickers
CRB
Fixx Pharmaceuticals Looks to Cure Hemophilia with Gene Editing
August 27, 2020
From PRUnderground
From Benzinga
Japan's Astellas To Buy Gene Therapy Company Audentes For $3B Cash
December 03, 2019
From Benzinga
Cash-Strapped Abeona's Stock Skyrockets As Gene Therapy Company Explores Strategic Options
September 03, 2019
Tickers
ABEO
From Benzinga
From Benzinga
Mustang Bio Gallops Higher On Positive Gene Therapy Results For Deadly 'Bubble Boy Disease'
April 18, 2019
From Benzinga
Fibrocell Strikes Funding Deal For Gene Therapy Candidate
April 15, 2019
From Benzinga
6 Gene Therapy M&A Targets On The Radar
March 27, 2019
From Benzinga
From Benzinga
From PRLog
Novartis CEO: 4 factors can help the industry price and pay for lifesaving cell and gene therapies
November 26, 2018
Tickers
NOVN
From CNBC.com News
Wells Fargo Bullish On Applied Genetic Technologies Ahead Of Program Update
September 24, 2018
From Benzinga
Sarepta Therapeutics CEO has a 'big ambition' for muscular dystrophy gene therapy
September 07, 2018
Tickers
SRPT
Tags
Health Care/Pharmaceuticals Biotechnology and Life Sciences/Biotechnology
Health Care/Pharmaceuticals Biotechnology and Life Sciences
Clinical trials
From CNBC.com News
Aldevron and Odylia form partnership for gene therapy treatments of ultra-rare diseases
June 27, 2018
From PRLog
Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives
June 23, 2018
From Benzinga
Tags
Health Care/Pharmaceuticals Biotechnology and Life Sciences
Biotechnology
Intellia Therapeutics Inc
From CNBC.com News
From PRLog
Investigating Groundbreaking Treatments for Rare Disease
April 04, 2018
Tech giants like Google and Facebook are 'ripe for the plucking,' says investor Jim Mellon
March 28, 2018
From CNBC.com News
On Rare Disease Day, a Focus on a Painful Skin Disease
February 27, 2018
From DGI Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.